Journey Medical Intrinsic Value Calculator – Journey Medical Pioneers Innovative Dermatological Care Solutions

December 9, 2023

☀️Trending News

Journey Medical ($NASDAQ:DERM) is an innovative leader when it comes to dermatological care solutions. Through its strategic evolution in dermatological care, the company has made significant advances in providing care for a variety of skin conditions. At Journey Medical, their goal is to bring the latest technology and best practices in skin care to their customers. They strive to maintain a high standard of quality and safety by utilizing a highly trained staff and modern technology. They offer a wide range of treatments from skin cancer detection and treatment to laser treatments for cosmetic purposes. They also provide comprehensive patient education on skin care, healing, and preventive strategies such as sun protection. In addition to their cutting-edge treatments, Journey Medical also offers a diverse portfolio of products and services.

This includes medications, skin care products, home care products, aesthetic procedures, and lab testing. All of these products and services are designed to improve the overall health and wellness of their patients. Journey Medical’s dedication to providing excellent dermatological care and innovative treatments has enabled them to stay ahead of the competition in their field. They are committed to providing cost-effective solutions that meet the needs of their patients and allow them to reach their health goals. This dedication to excellence has allowed them to build a strong reputation and continually provide the best care possible for their patients.

Market Price

On Friday, JOURNEY MEDICAL‘s stock opened at $6.7 and closed at $5.8, a plunge of 12.9% from the previous closing price of 6.7. This decrease in stock price has surprised investors as it is a considerable drop in just one day. However, despite the sudden downturn, JOURNEY MEDICAL remains at the forefront of modern healthcare solutions and continues to develop new products that improve patient care. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Journey Medical. More…

    Total Revenues Net Income Net Margin
    79.89 -12.35 -12.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Journey Medical. More…

    Operations Investing Financing
    17.92 -5 -23.07
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Journey Medical. More…

    Total Assets Total Liabilities Book Value Per Share
    65.92 48.54 0.94
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Journey Medical are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    28.3% -12.5%
    FCF Margin ROE ROA
    41.2% -71.6% -9.4%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Journey Medical Intrinsic Value Calculator

    GoodWhale analysts have performed a financial analysis of JOURNEY MEDICAL. Using our proprietary Valuation Line tool, we have calculated that the intrinsic value of JOURNEY MEDICAL’s share is around $3.2. However, the market trading price of JOURNEY MEDICAL stock is currently at $5.8, which indicates an overvaluation of 81.3%. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    Journey Medical Corp is one of the leading medical research companies in the industry, competing with several other prominent firms such as Nutri Pharmaceuticals Research Inc, Gaia Grow Corp, and CBD Life Sciences Inc. With a commitment to innovative research and development, Journey Medical Corp is dedicated to providing cutting-edge technology and treatments that make a real difference in people’s lives.

    – Nutri Pharmaceuticals Research Inc ($OTCPK:NRPR)

    Gaia Grow Corp is a leading provider of sustainable farming and agricultural technology solutions. The company is committed to improving the lives of farmers and helping them achieve higher yields and better quality produce. The company’s market cap of 180.18k as of 2023 reflects its successful implementation of innovative sustainable farming practices that are profitable and ecologically beneficial. Gaia Grow Corp has a strong Return on Equity (ROE) of 570.7%, indicating that their strategies and investments are generating high returns. With its strong financial performance, the company is well-positioned to continue its growth trajectory and further expand its presence in the global market.

    – Gaia Grow Corp ($BER:GG00)

    CBD Life Sciences Inc is a publicly traded company that specializes in the production, distribution, and sale of hemp-based products. As of 2023, the company’s market cap stands at 35.85k. This market cap provides investors with an indication of the company’s value. Additionally, the company’s Return on Equity (ROE) is -28.26%. ROE measures how well a company has been able to generate profits from its existing stockholder equity. Although the current ROE is negative, it indicates that the company has been able to put its funds in place to generate profits.

    Summary

    Journey Medical Corporation is a publicly traded company that specializes in dermatological care. The stock price of Journey Medical has recently moved down after investors analyzed the company’s strategic evolution. Specifically, investors observed that the company has increased its focus on developing treatments for skin diseases, as well as expanding its global reach by making collaborations with dermatologists.

    Additionally, investors have noted that Journey Medical has been investing heavily in research and development to develop new drugs and treatments. Overall, investors are concerned about the company’s short-term prospects, as the stock price drop indicates a lack of confidence.

    Recent Posts

    Leave a Comment